ConductScience.org, home

Gene · 5933

RBL1: RB transcriptional corepressor like 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RBL1: RB transcriptional corepressor like 1. Genes, record 5933. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5933

On this page

Gene

Symbol
RBL1
HGNC
Name
RB transcriptional corepressor like 1
HGNC
NCBI Gene ID
5933
NCBI Gene
HGNC ID
HGNC:9893
HGNC
Ensembl
ENSG00000080839
NCBI Gene
Aliases
CP107, PRB1, cp107, p107
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P28749Retinoblastoma-like protein 11,06810Ensembl, GeneID, HGNC

Source UniProt

Patents30

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-299592P28749Espacenet
JP 2025529142 A2025-09-043680P28749Espacenet
US 12371689 B22025-07-293680P28749Espacenet
JP 2025517969 A2025-06-129592P28749Espacenet
JP 2024123008 A2024-09-108178P28749Espacenet
US 11708396 B22023-07-252332P28749Espacenet
US 11446398 B22022-09-2072903P28749Espacenet
JP 2022524081 A2022-04-27175874P28749Espacenet
US 11078247 B22021-08-039418P28749Espacenet
US 10501513 B22019-12-108178P28749Espacenet

1 to 10 of 30

See all 30 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,909

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRBL1 papersNewest fiscal year
P30CA008748Cancer Center Support Grant152025
T32CA009302Leveraging innovative technologies in basic and clinical cancer research132025
P01CA022443Molecular Biology and Genetics of Human Tumor Viruses122025
P01CA013106Targeting Transcription and Splicing in Cancer102025
P30CA016672Cancer Center Support Grant102025
P01CA019014Viral Oncogenesis, Latency, and Replication72025
P50CA168504Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer72025
P30CA014520UW Comprehensive Cancer Center Support62025
P30CA006927Comprehensive Cancer Center Program at Fox Chase52025
P30CA016058Cancer Center Support Grant52025

1 to 10 of 1,909Source NIH's project files

See all 1,909 nih grants

Papers2,741

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Predicting gene compensation in disease with graph embedding techniques.Artif Intell Med202642632343PubTator, text miningPubMed
Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue.Curr Obes Rep202641848823PubTator, text miningPubMed
Exploiting cellular senescence in hematologic malignancies.Transl Oncol202641844438PubTator, text miningPubMed
Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review.Wound Repair Regen202641787822PubTator, text miningPubMed
The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion.Front Oncol202641783438PubTator, text miningPubMed
Beyond Oncogenes: Selectively Targeting Whole-Tumor Cell Growth Regulation.Drug Des Devel Ther202641769264PubTator, text miningPubMed
Mechanisms of the Antiproliferative Effects of SIRT6 Inhibition in Melanoma: A Multi-Omics Analysis.Cancers (Basel)202641749843PubTator, text miningPubMed
Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer.Research (Wash D C)202641743623PubTator, text miningPubMed
Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance.J Natl Cancer Cent202641738032PubTator, text miningPubMed
Targeted therapy for liver cancer: Current status and future directions.Bioimpacts202541716515PubTator, text miningPubMed

1 to 10 of 2,741

See all 2,741 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/5933

GET https://conductscience.org/api/genes/v1/5933/patents?page=2